|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5858 USD | -3.49% |
|
-1.10% | -37.09% |
| 16/01 | Jaguar Health Inc - Co & unit entered license agreement with Woodward Specialty LLC - SEC filing | RE |
| 06/01 | Jaguar Health, Inc. announced that it has received $0.35 million in funding | CI |
Evolution of the Average Target: Jaguar Health, Inc.
Evolution of the Target Price: Jaguar Health, Inc.
Changes in Analyst Recommendations: Jaguar Health, Inc.
69ce86b265.qdS65F2VXepWrb_RoUrC9f4vCePCDKoZMy74ehH3bBw.7rfLjwnECZMb54aDzSLvkZ9cZ7n3YMVgC02JOV-DGEr-ld6vGKQwrBLO-g~a74e469d9fd80803b473711d1893f84d
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +5,666.06% | |||
| +18.36% | |||||
| -3.99% | |||||
| +11.07% | |||||
| -0.98% | |||||
| +4.41% | |||||
| -7.06% | |||||
| +3.54% | |||||
| +24.73% | |||||
| -6.17% | |||||
| Average | +571.00% | |||||
| Weighted average by Cap. | +6.36% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.5858USD
Average target price
7.500USD
Spread / Average Target
+1,180.30%
High Price Target
7.500USD
Spread / Highest target
+1,180.30%
Low Price Target
7.500USD
Spread / Lowest Target
+1,180.30%
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| Cantor Fitzgerald |
SellBuy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.5858USD
Average target price
7.500USD
Spread / Average Target
+1,180.30%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- JAGX Stock
- Consensus Jaguar Health, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition